Skip to main content
. 2022 Mar 2;11(5):1377. doi: 10.3390/jcm11051377

Figure 4.

Figure 4

Time course of eyelid margin abnormalities, meibomian gland expressibility (MGX), and meibum quality in the intense pulsed light (IPL)–meibomian gland expression (MGX) and control groups. (A) Changes of lid margin abnormality before and after treatment. (B) Changes of MGX before and after treatment. (C) Changes of meibum quality before and after treatment. All follow-up assessments were compared to the baseline (time 0) values (* p < 0.05, ** p < 0.001).